Replies to post #51464 on Biotech Values

[Aiming4]

Dew - why would you think there's a possibility of no interest in CX717 for ADHD?

The ADHD trial results last year certainly seemed good enough to warrant BP interest.

And why do you think Cortex doing a financing has hurt the credibility of the company?

I know of few cases where longs aren't disappointed in a PIPE for a development stage biotech, but that doesn't raise any credibility issues.

[alertmeipp]

COR - CX717 partnership was up to term-sheet level prior to the hold. The interest is proven.